Digirad (DRAD) Receives 510(k) Clearance from FDA for Cardius X-ACT Rapid Cardiac SPECT/VCT Imager
Tweet Send to a Friend
Digirad Corporation (Nasdaq: DRAD) today announced that it has received 510(k) clearance from the US FDA, enabling the Company to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
